Two years into the coronavirus disease 2019 (COVID-19) pandemic and following several hot debates, the world’s first COVID-19 human challenge trial has recently been published by Killingley et al. We review its findings and explain why this particular juncture in time makes additional challenge trials for COVID-19 and for other diseases justified and important.
All Keywords
【저자키워드】 COVID-19, Controlled human infection model, Research Ethics, human challenge trials, vaccine ethics,
【저자키워드】 COVID-19, Controlled human infection model, Research Ethics, human challenge trials, vaccine ethics,